期刊
NATURE REVIEWS CANCER
卷 20, 期 1, 页码 57-70出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41568-019-0226-5
关键词
-
类别
资金
- Ludwig Institute for Cancer Research
- National Institute for Neurological Diseases and Stroke [NS73831]
- Defeat GBM Program of the National Brain Tumour Society
- Ben and Catherine Ivy Foundation
- Nvidia Foundation
- Sharpe/National Brain Tumour Society Research Program
Altered cellular metabolism is a hallmark of gliomas. Propelled by a set of recent technological advances, new insights into the molecular mechanisms underlying glioma metabolism are rapidly emerging. In this Review, we focus on the dynamic nature of glioma metabolism and how it is shaped by the interaction between tumour genotype and brain microenvironment. Recent advances integrating metabolomics with genomics are discussed, yielding new insight into the mechanisms that drive glioma pathogenesis. Studies that shed light on interactions between the tumour microenvironment and tumour genotype are highlighted, providing important clues as to how gliomas respond to and adapt to their changing tissue and biochemical contexts. Finally, a road map for the discovery of potential new glioma drug targets is suggested, with the goal of translating these new insights about glioma metabolism into clinical benefits for patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据